{
 "PrintNo":"A345","Session":2021,"Chamber":"ASSEMBLY","BillType":"Assembly","Published":"2020-12-23T14:50:54.782195Z",
 "Status":"IN_ASSEMBLY_COMM","Committee":"Health",
 "Milestones":[{"Type":"IN_ASSEMBLY_COMM","Date":"2022-01-05","Committee":"Health"}],
 "Actions":[
  {"Text":"REFERRED TO HEALTH","Date":"2021-01-06","Chamber":"ASSEMBLY"},
  {"Text":"REFERRED TO HEALTH","Date":"2022-01-05","Chamber":"ASSEMBLY"}
 ],
 "Sponsors":[{"ID":610,"Name":"Edward Braunstein","Short":"BRAUNSTEIN"},{"ID":906,"Name":"Rebecca Seawright","Short":"SEAWRIGHT"}],
 "Title":"Relates to labeling prescription bottles of opioids",
 "Summary":"Requires prescription bottles containing opioids to have a label affixed concerning the addictive nature of the drug.",
 "LawSection":"Public Health Law","LawCode":"Amd ยง3333, Pub Health L",
 "ActClause":"AN ACT to amend the public health law, in relation to labeling prescription bottles of opioids",
 "PreviousVersions":["A10356-2015","A7460-2017","A2872-2019"]
}